• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IgG2b上的碳水化合物链:有效反馈免疫抑制的必要条件。

Carbohydrate chains on IgG2b: a requirement for efficient feedback immunosuppression.

作者信息

Heyman B, Nose M, Weigle W O

出版信息

J Immunol. 1985 Jun;134(6):4018-23.

PMID:3872908
Abstract

The in vitro immunosuppressive ability of a monoclonal IgG2b-anti-trinitrophenyl antibody lacking carbohydrate chains (GORK-Tm) has been compared with the immunosuppressive ability of the intact antibody (GORK). The carbohydrate depletion of GORK-Tm was achieved by culturing the GORK hybridoma cells in media containing tunicamycin, an inhibitor of glycosylation. Both antibodies have been shown to have the same antigen and protein A-binding capacity, although GORK-Tm is deficient in complement fixation, antibody-dependent cellular cytotoxicity, binding to Fc receptors on macrophages, and rapid elimination of antigen-antibody complexes from the circulation. It is shown in these studies that although GORK antibodies are efficient immunosuppressors, suppressing up to 95% of the plaque-forming cell response, GORK-Tm antibody preparations with identical hemagglutinating and antigen-binding capacity are highly deficient in suppressing the immune response. These findings are of interest in two ways. First, it shows that the carbohydrate chains are of great importance for the immunosuppressive effects of IgG. Secondly, it also shows that the isotype IgG2b, in addition to all other murine isotypes, can efficiently suppress the humoral immune response.

摘要

已将缺乏碳水化合物链的单克隆IgG2b抗三硝基苯基抗体(GORK-Tm)的体外免疫抑制能力与完整抗体(GORK)的免疫抑制能力进行了比较。通过在含有衣霉素(一种糖基化抑制剂)的培养基中培养GORK杂交瘤细胞来实现GORK-Tm的碳水化合物缺失。两种抗体均显示具有相同的抗原和蛋白A结合能力,尽管GORK-Tm在补体固定、抗体依赖性细胞毒性、与巨噬细胞上Fc受体的结合以及从循环中快速清除抗原-抗体复合物方面存在缺陷。这些研究表明,尽管GORK抗体是有效的免疫抑制剂,可抑制高达95%的噬斑形成细胞反应,但具有相同血凝和抗原结合能力的GORK-Tm抗体制剂在抑制免疫反应方面高度不足。这些发现从两个方面来看很有意思。第一,它表明碳水化合物链对IgG的免疫抑制作用非常重要。第二,它还表明除所有其他鼠类同种型外,同种型IgG2b也能有效抑制体液免疫反应。

相似文献

1
Carbohydrate chains on IgG2b: a requirement for efficient feedback immunosuppression.IgG2b上的碳水化合物链:有效反馈免疫抑制的必要条件。
J Immunol. 1985 Jun;134(6):4018-23.
2
Complement activation is not required for IgG-mediated suppression of the antibody response.IgG介导的抗体反应抑制并不需要补体激活。
Eur J Immunol. 1988 Nov;18(11):1739-43. doi: 10.1002/eji.1830181113.
3
Fc receptors on cultured myeloma and hybridoma cells.培养的骨髓瘤细胞和杂交瘤细胞上的Fc受体
J Immunol. 1985 Mar;134(3):1774-9.
4
Immunoregulation by monoclonal sheep erythrocyte-specific IgG antibodies: suppression is correlated to level of antigen binding and not to isotype.单克隆绵羊红细胞特异性IgG抗体的免疫调节:抑制作用与抗原结合水平相关,而非与同种型相关。
J Immunol. 1984 Mar;132(3):1136-43.
5
Therapeutic potential of rat monoclonal antibodies: isotype specificity of antibody-dependent cell-mediated cytotoxicity with human lymphocytes.大鼠单克隆抗体的治疗潜力:人淋巴细胞抗体依赖性细胞介导的细胞毒性的同种型特异性
J Immunol. 1985 May;134(5):3056-61.
6
Modulation of the humoral immune response by antibody-mediated antigen targeting to complement receptors and Fc receptors.通过抗体介导的抗原靶向补体受体和Fc受体来调节体液免疫反应。
J Immunol. 1999 Mar 15;162(6):3125-30.
7
Monoclonal antibodies against T cell differentiation antigens initiate stimulation of monocyte/macrophage oxidative metabolism.针对T细胞分化抗原的单克隆抗体可启动单核细胞/巨噬细胞氧化代谢的刺激。
J Immunol. 1983 Nov;131(5):2500-7.
8
Dual immunoregulatory effects of monoclonal IgG-antibodies: suppression and enhancement of the antibody response.单克隆IgG抗体的双重免疫调节作用:抗体反应的抑制与增强
Scand J Immunol. 1989 Apr;29(4):439-48. doi: 10.1111/j.1365-3083.1989.tb01143.x.
9
All classes of murine IgG antibody mediate macrophage phagocytosis and lysis of erythrocytes.所有类别的小鼠IgG抗体都介导巨噬细胞对红细胞的吞噬作用和裂解作用。
J Immunol. 1980 Nov;125(5):1885-8.
10
Analysis of the monocyte Fc receptors and antibody-mediated cellular interactions required for the induction of T cell proliferation by anti-T3 antibodies.抗T3抗体诱导T细胞增殖所需的单核细胞Fc受体及抗体介导的细胞相互作用分析。
J Immunol. 1985 Jul;135(1):165-71.

引用本文的文献

1
Antibody feedback regulation.抗体反馈调节
Immunol Rev. 2024 Nov;328(1):126-142. doi: 10.1111/imr.13377. Epub 2024 Aug 23.
2
Maternal gatekeepers: How maternal antibody Fc characteristics influence passive transfer and infant protection.母体把关者:母体抗体Fc特性如何影响被动转运及婴儿保护
PLoS Pathog. 2020 Mar 26;16(3):e1008303. doi: 10.1371/journal.ppat.1008303. eCollection 2020 Mar.
3
The history of IgG glycosylation and where we are now.IgG 糖基化的历史和现状。
Glycobiology. 2020 Mar 20;30(4):202-213. doi: 10.1093/glycob/cwz065.
4
Biological roles of glycans.聚糖的生物学作用。
Glycobiology. 2017 Jan;27(1):3-49. doi: 10.1093/glycob/cww086. Epub 2016 Aug 24.
5
Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies.母体抗体:临床意义、干扰免疫反应的机制及可能的疫苗接种策略。
Front Immunol. 2014 Sep 16;5:446. doi: 10.3389/fimmu.2014.00446. eCollection 2014.
6
Insights into the regulatory mechanism controlling the inhibition of vaccine-induced seroconversion by maternal antibodies.深入了解控制母源抗体抑制疫苗诱导血清转化的调控机制。
Blood. 2011 Jun 9;117(23):6143-51. doi: 10.1182/blood-2010-11-320317. Epub 2011 Feb 28.
7
Efficient IgG-mediated suppression of primary antibody responses in Fcgamma receptor-deficient mice.在缺乏Fcγ受体的小鼠中,高效IgG介导的对初次抗体应答的抑制作用。
Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2244-9. doi: 10.1073/pnas.96.5.2244.
8
Structural changes in the oligosaccharide moiety of human IgG with aging.人免疫球蛋白G(IgG)寡糖部分随衰老的结构变化。
Glycoconj J. 1998 Jul;15(7):683-9. doi: 10.1023/a:1006936431276.
9
Detection of human asialo-alpha(1)-acid glycoprotein using a heterosandwich immunoassay in conjunction with the light addressable potentiometric sensor.
Glycoconj J. 1996 Aug;13(4):637-41. doi: 10.1007/BF00731452.
10
Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment].静脉注射免疫球蛋白含有特异性抗体,可抑制葡萄球菌毒素超抗原激活T细胞[见评论]。
J Clin Invest. 1993 Feb;91(2):602-7. doi: 10.1172/JCI116240.